Lexicon Pharmaceuticals Investors

Lexicon Pharmaceuticals is a private equity firm based in The Woodlands, Texas, founded in 1995 The firm specializes in the development and commercialization of innovative therapies, particularly in the fields of metabolic and autoimmune diseases Lexicon Pharmaceuticals has a significant investment scale, with a focus on advancing its proprietary drug discovery platform The firm is committed to fostering strategic partnerships and collaborations to enhance its research and development efforts With a strong emphasis on scientific excellence, Lexicon Pharmaceuticals aims to deliver transformative solutions to unmet medical needs

Technology: Biologics
Headquarters: USA
Total Funding: $36M
Last Funding Type: Series C
Founded Date: 1995
Investors Number: 4
Industry: FemTech
Employee Number: 251-500
Estimated Revenue: $100M to $500M
Investor Type: Private Equity Firms
Funding Status: IPO